Post-Conference Report
This post-conference report offers a complete guide to all the oncolytic viruses topics and provides you with an abstract analysis split into data type, viral family, and clinical abstract properties. Also the clinical, trial outline, and preclinical abstract summaries.
More Resources
H1 2024 Oncolytic Viruses Landscape Review
Investment Trends in Early-Stage Biopharma: A Beacon Data Perspective
Beacon Oncolytic Viruses: 2024 ASCO Annual Meeting Abstracts
Find out more
Beacon is the essential decision-support tool for developers of complex therapeutics. Our market-defining, proprietary ontologies, combined with the most accurate and comprehensive life sciences data, provide our customers with unparalleled visibility of the drug and trial landscape.
With Beacon, you can make drug development decisions with confidence. This is why 23 of the world’s top 25 drug developers trust us.
Speak with our Team
Our dedicated account and research teams can help you with questions by showing you how this insight and data is collated on Beacon.
